Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?

참고문헌 (9)

1. Viget N, "Opportunistic infections in patients with inflammatory bowel disease : prevention and diagnosis", Gut, 57, pp.549~558 (2008)
2. Bonovas S, "Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease : a systematic review and network meta-analysis", Clin Gastroenterol Hepatol, 14, pp.1385~1397 (2016)
3. Haruhiko Ogata, "Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study", Intestinal research, 19(4), pp.419~429 (2021), 대한장연구학회[DOI]
4. Kucharzik T, "ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease", J Crohns Colitis, 15, pp.879~913 (2021)
5. Yang Hong, "Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study", Gut and Liver, 16(5), pp.726~735 (2022), 거트앤리버 소화기연관학회협의회[DOI]
6. Soo-Kyung Park, "Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases", Intestinal research, 18(1), pp.18~33 (2020), 대한장연구학회
7. Sahil Khanna, "Management of Clostridioides difficile infection in patients with inflammatory bowel disease", Intestinal research, 19(3), pp.265~274 (2021), 대한장연구학회[DOI]
8. Ben Musa R, "Hepatitis B vaccination in patients with inflammatory bowel disease", World J Gastroenterol, 20, pp.15358~15366 (2014)
9. Johnson S, "Clinical practice guideline by the Infectious Diseases Society of America(IDSA)and Society for Healthcare Epidemiology of America(SHEA) : 2021 focused update guidelines on management of Clostridioides difficile infection in adults", Clin Infect Dis, 73, pp.755~757 (2021)

관련 논문AI추천